-+ 0.00%
-+ 0.00%
-+ 0.00%

Rapid Micro Biosystems publishes corporate presentation on Growth Direct microbial QC automation platform

PUBT·05/13/2026 20:58:50
Listen to the news
Rapid Micro Biosystems publishes corporate presentation on Growth Direct microbial QC automation platform
  • Rapid Micro Biosystems highlighted 2025 total revenue of $33.6 million, recurring revenue of $17.8 million, 190 cumulative system placements, 155 cumulative validations.
  • Q1 2026 preliminary results showed total revenue of $8 million, recurring revenue of $5.1 million, 6 systems placed, 5 systems validated.
  • 2026 revenue guidance reaffirmed at $37 million-$41 million.
  • Presentation outlined a distribution and collaboration partnership with MilliporeSigma, including a global 5-year co-exclusive right to sell Growth Direct systems and consumables.
  • Company flagged expected H2 2026 release of next-generation cloud-native software, targeting AI-driven analytics and insights for Growth Direct customers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Micro Biosystems Inc. published the original content used to generate this news brief on May 14, 2026, and is solely responsible for the information contained therein.